Probiotical cell fragments (PCFs) are structural components of the probiotic cell lysate(s) and exhibit similar beneficial effects on the host as live probiotic bacteria. With cell fragment technology (CFT?), the stru...Probiotical cell fragments (PCFs) are structural components of the probiotic cell lysate(s) and exhibit similar beneficial effects on the host as live probiotic bacteria. With cell fragment technology (CFT?), the structural fragments are isolated and purified from live probiotic cells. While observed to be strain-dependent as in the case of live probiotics, orally administered PCFs demonstrated a broad spectrum of immune modulation functions;anti-allergy;anti-inflammation;anti-bacterial and anti-viral properties;anti-mutagenic;and radioprotective and detoxification abilities in humans and animals. The PCFs mechanisms of action include events of motifs of cell wall peptidoglycans, DNA motifs, nucleotide containing components, lipoteichoic acids (LPAs), surface layer (S-layer) proteins, and cytoplasmic proteins. Different immunological in vivo-in vitro tests have shown that PCFs, essentially, have the ability to stimulate the macrophages, and induce cytokines such as interleukins, tumor necrosis factors (TNFs), interferons (IFNs), and natural killer (NK) cells. PCFs may be used as ingredients for foods and beverages or as nutritional supplements with long term stability and shelf-life up to 5 years. PCFs may also be used as health restorative ingredients in cosmetic products. The outcome of probiotics CFT? stands as an advantage to the food and pharmaceutical industries, regarding the formulation of novel products with unadulterated sensory characteristics of origin. Hence, PCFs are being characterized here as “novel nutraceutical ingredients” for health maintenance in both humans and animals.展开更多
The evidence in this paper indicates that the alarming increase of common allergies can be reduced by the intake of particular “probiotics” or “paraprobiotics” along with food. This appears to build a consensus in...The evidence in this paper indicates that the alarming increase of common allergies can be reduced by the intake of particular “probiotics” or “paraprobiotics” along with food. This appears to build a consensus in the pharmaceutical and food communities about the role of probiotics in the prevention and treatments of common allergies. Food allergy is one of the common allergies, defined as an adverse health effect arising from a specific immune response that occurs reproducibly on exposure to a given food. Improving the digestion of foods and maintaining a healthy gastrointestinal (GI) tract is certainly critical to controlling food allergens. Therefore, the association between a leaky gut or an impaired intestinal permeability and food-allergenic reactions is explained. Gluten has been found to be somehow a justification for protein allergy, and should, therefore, be avoided by people with celiac disease. In several, in vitro models, surface layer (S- layer) proteins of selective paraprobiotics have shown potential in alleviating food allergies and intestinal disorders. Notably, lactobacilli paraprobiotics have proven to be the immediate immunomodulators against common allergies and other diseases, including viral (flu, hepatitis C), bacterial (bronchitis), asthma, chronic fatigue, fibromyalgia, gastrointestinal distress, and autism disorders in humans.展开更多
Parkinson’s disease is characterized by synucleinopathy-associated neurodegeneration.Previous studies have shown that glucagon-like peptide-1(GLP-1)has beneficial effects in a mouse model of Parkinson’s disease indu...Parkinson’s disease is characterized by synucleinopathy-associated neurodegeneration.Previous studies have shown that glucagon-like peptide-1(GLP-1)has beneficial effects in a mouse model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.However,the effect of GLP-1 on intrinsic synuclein malfunction remains unclear.In this study,we investigated the effect of Lactococcus lactis MG1363-pMG36e-GLP-1 on parkinsonism in SncaA53T transgenic mice and explored the underlying mechanisms.Our data showed that Lactococcus lactis MG1363-pMG36e-GLP-1 inhibited dopaminergic neuronal death,reduced pathological aggregation ofα-synuclein,and decreased movement disorders in SncaA53T transgenic mice.Furthermore,Lactococcus lactis MG1363-pMG36e-GLP-1 downregulated lipopolysaccharide-related inflammation,reduced cerebral activation of microglia and astrocytes,and promoted cell survival via the GLP-1 receptor/PI3K/Akt pathway in the substantia nigra.Additionally,Lactococcus lactis MG1363-pMG36e-GLP-1 decreased serum levels of pro-inflammatory molecules including lipopolysaccharide,lipopolysaccharide binding protein,interleukin-1β,and interleukin-6.Gut histopathology and western blotting further revealed that Lactococcus lactis MG1363-pMG36e-GLP-1 increased the expression of gut integrity-related proteins and reduced lipopolysaccharide-related inflammation by reversing gut dysbiosis in SncaA53T transgenic mice.Our findings showed that the beneficial effect of Lactococcus lactis MG1363-pMG36e-GLP-1 on parkinsonism traits in SncaA53T transgenic mice is mediated by microglial polarization and the reversal of dysbiosis.Collectively,our findings suggest that Lactococcus lactis MG1363-pMG36e-GLP-1 is a promising therapeutic agent for the treatment of Parkinson’s disease.展开更多
The term“gut microbiota”primarily refers to the ecological community of various microorganisms in the gut,which constitutes the largest microbial community in the human body.Although adequate bowel preparation can i...The term“gut microbiota”primarily refers to the ecological community of various microorganisms in the gut,which constitutes the largest microbial community in the human body.Although adequate bowel preparation can improve the results of colonoscopy,it may interfere with the gut microbiota.Bowel preparation for colonoscopy can lead to transient changes in the gut microbiota,potentially affecting an individual’s health,especially in vulnerable populations,such as patients with inflammatory bowel disease.However,measures such as oral pro-biotics may ameliorate these adverse effects.We focused on the bowel prepa-ration-induced changes in the gut microbiota and host health status,hypothesized the factors influencing these changes,and attempted to identify measures that may reduce dysbiosis,thereby providing more information for individualized bowel preparation for colonoscopy in the future.展开更多
BACKGROUND: Sepsis, a common acute and critical disease, leads to 11 million deaths annually worldwide. Probiotics are living microorganisms that are beneficial to the host and may benefit sepsis outcomes, but their e...BACKGROUND: Sepsis, a common acute and critical disease, leads to 11 million deaths annually worldwide. Probiotics are living microorganisms that are beneficial to the host and may benefit sepsis outcomes, but their effects are stil inconclusive. This study aimed to evaluate the overal eff ect of probiotics on the prognosis of patients with sepsis.DATA RESOURCES: We searched several sources for published/presented studies, including Pub Med, EMBASE, Web of Science, the Cochrane Library and the US National Library of Medicine Clinical Trials Register(www.clinicaltrials.gov) updated through July 30, 2023, to identify all relevant randomized controlled trials(RCTs) or observational studies that assessed the effectiveness of probiotics or synbiotics in patients with sepsis and reported mortality. We focused primarily on mortality during the study period and analyzed secondary outcomes, including 28-day mortality, in-intensive care unit(ICU) mortality and other outcomes.RESULTS: Data from 405 patients in five RCTs and 108 patients in one cohort study were included in the analysis. The overall quality of the studies was satisfactory, but clinical heterogeneity existed. All adult studies reported a tendency for probiotics to reduce the mortality of patients with sepsis, and most studies reported a decreasing trend in the incidence of infectious complications, length of ICU stay and duration of antibiotic use. There was only one RCT involving children.CONCLUSION: Probiotics show promise for improving the prognosis of patients with sepsis, including reducing mortality and the incidence of infectious complications, particularly in adult patients. Despite the limited number of studies, especially in children, these findings will be encouraging for clinical practice in the treatment of sepsis and suggest that gut microbiota-targeted therapy may improve the prognosis of patients with sepsis.展开更多
The gut microbiome comprises a vast community of microbes inhabiting the human alimentary canal,playing a crucial role in various physiological functions.These microbes generally live in harmony with the host;however,...The gut microbiome comprises a vast community of microbes inhabiting the human alimentary canal,playing a crucial role in various physiological functions.These microbes generally live in harmony with the host;however,when dysbiosis occurs,it can contribute to the pathogenesis of diseases,including osteoporosis.Osteoporosis,a systemic skeletal disease characterized by reduced bone mass and increased fracture risk,has attracted significant research attention concerning the role of gut microbes in its development.Advances in molecular biology have highlighted the influence of gut microbiota on osteoporosis through mechanisms involving immunoregulation,modulation of the gut-brain axis,and regulation of the intestinal barrier and nutrient absorption.These microbes can enhance bone mass by inhibiting osteoclast differentiation,inducing apoptosis,reducing bone resorption,and promoting osteoblast proliferation and maturation.Despite these promising findings,the therapeutic effectiveness of targeting gut microbes in osteoporosis requires further investigation.Notably,gut microbiota has been increasingly studied for their potential in early diagnosis,intervention,and as an adjunct therapy for osteoporosis,suggesting a growing utility in improving bone health.Further research is essential to fully elucidate the therapeutic potential and clinical application of gut microbiome modulation in the management of osteoporosis.展开更多
Probiotic supplementation enhances the abundance of gutassociated Rhodobacteraceae species,critical symbionts contributing to the health and physiological fitness of Litopenaeus vannamei.Understanding the role of Rhod...Probiotic supplementation enhances the abundance of gutassociated Rhodobacteraceae species,critical symbionts contributing to the health and physiological fitness of Litopenaeus vannamei.Understanding the role of Rhodobacteraceae in shaping the shrimp gut microbiota is essential for optimizing probiotic application.This study investigated whether probiotics benefit shrimp health and fitness via the recruitment of Rhodobacteraceae commensals in the gut.Probiotic supplementation significantly enhanced feed conversion efficiency,digestive enzyme activity,and immune responses,thereby promoting shrimp growth.Additionally,probiotics induced pronounced shifts in gut microbial composition,enriched gut Rhodobacteraceae abundance,and reduced community variability,leading to a more stable gut microbiome.Network analysis revealed that the removal of Rhodobacteraceae nodes disrupted gut microbial connectivity more rapidly than the removal of nonRhodobacteraceae nodes,indicating a disproportionate role of Rhodobacteraceae in maintaining network stability.Probiotic supplementation facilitated the migration of Rhodobacteraceae taxa from the aquatic environment to the shrimp gut while reinforcing deterministic selection in gut microbiota assembly.Transcriptomic analysis revealed that up-regulation of amino acid metabolism and NF-κB signaling pathways was positively correlated with Rhodobacteraceae abundance.These findings demonstrate that probiotic supplementation enriches key Rhodobacteraceae taxa,stabilizes gut microbial networks,and enhances host digestive and immune functions,ultimately improving shrimp growth performance.This study provides novel perspectives on the ecological and molecular mechanisms underlying the beneficial effects of probiotics on shrimp fitness.展开更多
This editorial,inspired by a recent study published in the World Journal of Gastrointestinal Oncology,covers the research findings on microbiota changes in various diseases.In recurrent colorectal polyps,the abundance...This editorial,inspired by a recent study published in the World Journal of Gastrointestinal Oncology,covers the research findings on microbiota changes in various diseases.In recurrent colorectal polyps,the abundances of Klebsiella,Parvimonas,and Clostridium increase,while those of Bifidobacterium and Lactoba-cillus decrease.This dysbiosis may promote the formation and recurrence of polyps.Similar microbial changes have also been observed in colorectal cancer,inflammatory bowel disease,autism spectrum disorder,and metabolic syndrome,indicating the role of increased pathogens and decreased probiotics in these conditions.Regulating the gut microbiota,particularly by increasing probiotic levels,may help prevent polyp recurrence and promote gut health.This microbial intervention strategy holds promise as an adjunctive treatment for patients with colorectal polyps.展开更多
BACKGROUND Food protein-induced enterocolitis syndrome(FPIES)is the most serious type of non-immunoglobulin E(IgE)-mediated food allergic reaction manifesting as sepsis-like symptom,which can lead to shock.Saccharomyc...BACKGROUND Food protein-induced enterocolitis syndrome(FPIES)is the most serious type of non-immunoglobulin E(IgE)-mediated food allergic reaction manifesting as sepsis-like symptom,which can lead to shock.Saccharomyces boulardii(S.boulardii),a probiotic prescribed frequently in clinical settings,has been reported to trigger FPIES in an infant with soy-triggered FPIES.In this report,we describe a new clinical FPIES in which S.boulardii was the sole triggering factor of acute FPIES adverse reaction in seven healthy infants.CASE SUMMARY Seven FPIES cases triggered by only S.boulardii were gathered from 2011 to the present.None of the patients had previously experienced any allergic reaction to cow’s milk,soy,or complementary food.The age of the patients was 4-10-months old,and the symptoms of FPIES developed after ingestion of S.boulardii,which is mostly prescribed for the treatment of gastroenteritis or antibiotic-associated diarrhea.All patients experienced severe repetitive vomiting 1-3 hours after S.boulardii ingestion.Extreme lethargy,marked pallor,and cyanosis were also observed.No IgE-mediated hypersensitivity developed in any patient.Diarrhea was followed by initial intense vomiting in approximately 5-10 hours after S.boulardii ingestion,and only one case showed bloody,purulent,and foul-smelling diarrhea.The patients stabilized quickly,mostly within 6 hours.Symptoms got all improved within 24 hours after discontinuation of S.boulardii.CONCLUSION S.boulardii can be the sole trigger of acute FPIES and be prescribed cautiously even in healthy children without FPIES.展开更多
The prevalence of bacterial digestive diseases in plateau animals has caused considerable losses to the Tibetan live‑stock industry.Therefore,this study aimed to isolate safe lactic acid bacteria(LAB)with beneficial p...The prevalence of bacterial digestive diseases in plateau animals has caused considerable losses to the Tibetan live‑stock industry.Therefore,this study aimed to isolate safe lactic acid bacteria(LAB)with beneficial probiotic proper‑ties to protect yaks from intestinal diseases.After 16S rDNA matching,four strains of Lactobacillus fermentum(A4),Pediococcus pentosaceus(A3.4 and A1.2),and Pediococcus acidilactici(B1.9)were isolated from the intestinal tissues and content of healthy yaks.The results indicated that A4 was more tolerant to bile salt(0.3%),while A3.4 had better stability in an acidic(pH=3.0)environment.The results of the antibacterial activity test suggested that the isolates inhibited most pathogenic bacteria by up to 20%,except for A3.4,which inhibited Pasteurella and Staphylococcus aureus by more than 20%.Moreover,the results of the antioxidant test demonstrated that A4 and A3.4 had potent antioxidant activity.In addition,the drug sensitivity test revealed that the isolates were susceptible to commonly used antibiotics.In terms of safety,the isolates promoted growth,enhanced intestinal development,and protected the intestinal barrier without causing any adverse effects.In conclusion,LAB isolated from yak intestinal contents are potential probiotics with excellent antibacterial properties.展开更多
BACKGROUND Diabetes is an epidemic condition affecting people globally with a high rate of morbidity and mortality.While various pharmacological and non-pharmacological treatment options are used,diabetes is still a n...BACKGROUND Diabetes is an epidemic condition affecting people globally with a high rate of morbidity and mortality.While various pharmacological and non-pharmacological treatment options are used,diabetes is still a non-treatable condition.Constant attempts are made to identify newer therapies that could support better management of the diabetes condition and improve overall quality of life.Numerous studies have supported the potential role of probiotics therapy in the diabetes condition.AIM To evaluate the efficacy of triple probiotic combination on glycaemic,metabolic,oxidative stress,and inflammatory parameters in the diabetic population.METHODS Randomized controlled trials evaluating the efficacy of the triple probiotic combination in diabetic patients were identified.The quality of the studies was evaluated using the PEDro scale while biasness between and within the studies was assessed using the Risk of Bias tool.Meta-analysis was conducted using RevMan software,and sensitivity analysis was performed using OpenMeta Analyst software.The study protocol was registered in PROSPERO(CRD42-024530999).RESULTS Five good-quality clinical trials were included.Low-to-moderate risk of bias was observed.Data from 300 participants were included(150 participants in both groups).Probiotics supplementation significantly improved glycaemic and insulin parameters(glucose level:-23.86 mg/dL;insulin level:-5.02μIU/mL;HOMA-IR:-1.82 score;QUICKI:+0.02 score;HOMA-B:-16.30 score;P<0.05 for all parameters),reduced oxidative stress and improved antioxidant parameters[TAC:+92.55 mmol/L;glutathione(GSH):+40.55μmol/L;nitric oxide(NO):+6.45μmol/L;malondialdehyde(MDA):-0.48μmol/L;hs-CRP:-2.24 mg/L;P<0.05 for all parameters except GSH],and improved lipid parameters(total cholesterol(TC):-3.43 mg/dL;triglycerides(TG):-4.26 mg/dL;low-density lipoprotein:-4.62 mg/dL;very low-density lipoprotein:-0.83 mg/dL;high-density lipoprotein(HDL):+1.83 mg/dL;TC/HDL ratio:-0.25;P<0.05 for HDL and TC/HDL ratio parameters)compared to the control group.CONCLUSION The combination of L.acidophilus,L.casei,and B.bifidum is effective in diabetic patients with cardio/renal complications.Further well-designed studies are warranted to support the results of current research.展开更多
BACKGROUND Depression is a common mental-health disorder worldwide.Several studies have demonstrated the effects of gut microbiota-targeting interventions,such as probiotics,prebiotics,synbiotics,and postbiotics(PPSP)...BACKGROUND Depression is a common mental-health disorder worldwide.Several studies have demonstrated the effects of gut microbiota-targeting interventions,such as probiotics,prebiotics,synbiotics,and postbiotics(PPSP),on depression.AIM To assess the potential benefits of PPSP on patients diagnosed with depressive disorder.METHODS A literature search of the PubMed,Web of Science,and Elsevier Science Direct databases for relevant studies published from database inception to March 2024 was performed.Studies that used a randomized controlled trial design and eva-luated differences in depression between PPSP and placebo were included.Depressive symptoms were assessed using a validated scale.Analysis was performed using Review Manager version 5.4(The Cochrane Collaboration,2020).RESULTS Fourteen studies comprising 906 patients with depressive symptoms were included.PPSP improved depression compared with placebo[SMD:-0.39(95%CI:-0.60 to-0.17);P<0.001].PPSP resulted in significant reductions in Hamilton Depression Rating Scale[MD:-1.72(95%CI:-2.57 to-0.88);P<0.001]and Beck Depression Inventory[MD:-2.69(95%CI:-4.67 to-0.71);P<0.001]scores.Sub-analysis confirmed the antidepressant effects of probiotics on depressive symp-toms[SMD:-0.32(95%CI:-0.48 to-0.16);P<0.001],with prebiotics exerting no apparent effect[SMD:-0.08(95%CI:-0.39 to-0.23);P=0.62],and synbiotics exerting statistically significant benefits[SMD:-1.09(95%CI:-1.45 to-0.73);P<0.001].CONCLUSION PPSP effectively alleviates depressive symptoms,and subgroup analysis supports the benefits of probiotics and synbiotics.Nevertheless,evidence supporting the use of PPSP for the treatment of depression remains insufficient.展开更多
Schizophrenia is a complex neuropsychiatric disorder characterized by cognitive,emotional,and behavioral impairments.The microbiota-gut-brain axis is crucial in its pathophysiology,mediating communication between the ...Schizophrenia is a complex neuropsychiatric disorder characterized by cognitive,emotional,and behavioral impairments.The microbiota-gut-brain axis is crucial in its pathophysiology,mediating communication between the gut and brain through neural,immune,endocrine,and metabolic pathways.Dysbiosis,or an imbalance in gut microbiota,is linked to neuroinflammation,systemic inflam-mation,and neurotransmitter disruptions,all of which contribute to the symp-toms of schizophrenia.Gut microbiota-derived metabolites,such as short-chain fatty acids,influence brain function,including immune responses and neurotrans-mitter synthesis.These findings suggest that microbial imbalances exacerbate schizophrenia,providing a novel perspective on the disorder’s underlying mechanisms.Emerging microbiota-targeted therapies—such as probiotics,prebiotics,dietary interventions,and fecal microbiota trans-plantation—show promise as adjunctive treatments,aiming to restore microbial balance and improve clinical outcomes.While further research is needed,targeting the micro-biota-gut-brain axis offers an innovative approach to schizophrenia management,with the potential to enhance patient outcomes and quality of life.展开更多
Hyperuricemia is a prevalent metabolic disorder resulting from dysregulation of purine metabolism,often accompanied by inflammation.It is characterized by an abnormal elevation in uric acid(UA)levels.In our investigat...Hyperuricemia is a prevalent metabolic disorder resulting from dysregulation of purine metabolism,often accompanied by inflammation.It is characterized by an abnormal elevation in uric acid(UA)levels.In our investigation,the combined treatment with Lactiplantibacillus plantarum DY1 and quercetin suppressed the activity of xanthine oxidase and adenosine deaminase,decreased the levels of UA,tumor necrosis factor alpha(TNF-α)and interleukin 1β(IL-β),downregulated gene expression of urate transporter 1(URAT1)and glucose transporter 9(GLUT9),and upregulated organic anion transporter 1(OAT1)and ATP-binding cassette transporter subfamily G member 2(ABCG2).The combination increased the abundance of Lactobacillus and decreased the abundance of norank_f_norank_o__Clostridia_UCG-014 and Roseburia.Metabolomics analysis revealed that the combination of probiotics and quercetin exhibited distinct metabolic pathways compared to their individual administrations.When compared to probiotics alone,the combination led to alterations in glutathione metabolism(oxidized glutathione and glutathione)as well as sphingolipid metabolism(sphingosine and sphinganine).When compared to quercetin alone,the combination resulted in variations in tryptophan metabolism(indole-3-acetamide,5-hydroxy-L-tryptophan,indoleacetaldehyde,3-(3-indolyl)-2-oxopropanoic acid,3-indoleacetic acid and 3-methylindole)along with purine metabolism(UA,xanthosine,cyclic adenosine monophosphate(cAMP),adenosine diphosphate(ADP)and adenosine monophosphate(AMP)).The subsequent fecal microbiota transplantation proved that the effect of the combination on reducing UA levels was mediated by the gut microbiota.Therefore,this new combination can be considered a promising adjuvant therapy capable of synergistically alleviating hyperuricemia.展开更多
Background Coccidiosis,caused by Eimeria parasites,is a major enteric disease in poultry,significantly impacting animal health,production performance,and welfare.This disease imposes a substantial economic burden,cost...Background Coccidiosis,caused by Eimeria parasites,is a major enteric disease in poultry,significantly impacting animal health,production performance,and welfare.This disease imposes a substantial economic burden,costing the global poultry industry up to$13 billion annually.However,effective mitigation strategies for coccidiosis remain elusive.While different chicken breeds exhibit varying resistance to coccidiosis,no commensal bacteria have been directly linked to this resistance.Methods To assess relative resistance of different breeds to coccidiosis,10-day-old Fayoumi M5.1,Leghorn Ghs6,and Cobb chickens were challenged with 50,000 sporulated Eimeria maxima oocysts or mock-infected.Body weight changes,small intestinal lesions,and fecal oocyst shedding were evaluated on d 17.Ileal and cecal digesta were collected from individual animals on d 17 and subjected to microbiome analysis using 16S rRNA gene sequencing.Results Fayoumi M5.1 chickens showed the lowest growth retardation,intestinal lesion score,fecal oocyst shedding,and pathobiont proliferation compared to Ghs6 and Cobb chickens.The intestinal microbiota of M5.1 chickens also differed markedly from the other two breeds under both healthy and coccidiosis conditions.Notably,group A Lactobacillus and Ligilactobacillus salivarius were the least prevalent in both the ileum and cecum of healthy M5.1 chickens,but became highly enriched and comparable to Ghs6 and Cobb chickens in response to coccidiosis.Conversely,Weissella,Staphylococcus gallinarum,and Enterococcus durans/hirae were more abundant in the ileum of healthy M5.1 chickens than in the other two breeds.Despite being reduced by Eimeria,these bacteria retained higher abundance in M5.1 chickens compared to the other breeds.Conclusions Fayoumi M5.1 chickens exhibit greater resistance to coccidiosis than Leghorn Ghs6 layers and Cobb broilers.Several commensal bacteria,including group A Lactobacillus,L.salivarius,Weissella,S.gallinarum,and E.durans/hirae,are differentially enriched in Fayoumi M5.1 chickens with strong correlation with coccidiosis resistance.These bacteria hold potential as probiotics for coccidiosis mitigation.展开更多
As a natural alternative to antibiotics,probiotics have considerable potential for use in livestock farming.However,the current use of probiotics in livestock poses potential public health risks due to inadequate regu...As a natural alternative to antibiotics,probiotics have considerable potential for use in livestock farming.However,the current use of probiotics in livestock poses potential public health risks due to inadequate regulations,including issues such as the inferior quality and dissemination of antibiotic resistance.In this study,95 non-duplicate commercial probiotic products for livestock were collected from different regions of China.Our findings revealed that the labeling compliance rate for Lactobacillus was the lowest,at just 11%,and approximately 33.3%of the products were contaminated with opportunistic pathogens containing various virulence and antibiotic-resistance genes(ARGs).Isolates of Bacillus and Enterococcus from the products exhibited diverse clonal types and geographical dispersion,whereas certain Enterococcus exhibited close phylogenetic relationships to clones associated with human infectious diseases.Compared with Bacillus and Lactobacillus,Enterococcus exhibited a higher prevalence of ARGs.Specifically,the oxazolidine-resistance gene optrA,which is located on novel transferable plasmids,was found in one isolate of Enterococcus faecium(E.faecium).Using chicken models,we observed that the optrA-positive E.faecium disrupts the normal intestinal microbiota in chickens and alters the abundance of intestinal resistome and mobile genetic elements(MGEs).Furthermore,metagenomic analysis revealed that the optrA gene can be transferred via transposon IS1216E to commensal intestinal bacteria,including Enterococcus cecorum(E.cecorum),Enterococcus gallinarum(E.gallinarum),and Lactobacillus crispatus(L.crispatus)species.In summary,our study confirms that the probiotic products used in Chinese livestock production present problems such as non-compliance with good manufacturing practice(GMP)production standards and insufficient elucidation of the molecular genetic background of probiotic strains.The widespread use of low-quality Enterococcus strains containing various ARGs as probiotics could disrupt intestinal homeostasis and serve as a reservoir and source of ARGs.We emphasize the importance of carefully evaluating the use of Enterococcus strains as probiotics to avoid potential negative effects on livestock and human health.展开更多
BACKGROUND Anhedonia,a hallmark symptom of major depressive disorder(MDD),is often resistant to common antidepressants.Preliminary evidence indicates that Pedio-coccus acidilactici(P.acidilactici)CCFM6432 may offer po...BACKGROUND Anhedonia,a hallmark symptom of major depressive disorder(MDD),is often resistant to common antidepressants.Preliminary evidence indicates that Pedio-coccus acidilactici(P.acidilactici)CCFM6432 may offer potential benefits in ame-liorating this symptomatology in patients with MDD.AIM To further assess the efficacy of P.acidilactici CCFM6432 in alleviating anhedonia in patients with MDD,using a combination of objective and subjective assessment tools.METHODS Adult patients with MDD exhibiting anhedonic symptoms were enrolled and randomly assigned to two treatment groups:One receiving standard antide-pressant therapy plus P.acidilactici CCFM6432,and the other receiving standard antidepressant treatment along with a placebo,for 30 days.Assessments were conducted at baseline and post-intervention using the Hamilton Depression Rating Scale(HAMD),Temporal Experience of Pleasure Scale(TEPS),and synchronous electroencephalography(EEG)during a"Doors Guessing Task."Changes in both clinical outcomes and EEG biomarkers,specifically the stimulus-preceding negativity(SPN)and feedback-related nega-tivity amplitudes,were analyzed.RESULTS Of the 92 screened participants,71 were enrolled and 55 completed the study(CCFM6432 group:n=27;Placebo group:n=28).No baseline differences were noted between the groups in terms of demographics,clinical assessments,or EEG metrics.A mixed-design analysis of variance revealed that the CCFM6432 group showed significantly greater improvements in both HAMD and TEPS scores compared to the Placebo group.Moreover,the CCFM6432 group demonstrated a significant increase in SPN amplitudes,which were inversely correlated with the improvements observed in HAMD scores.No such changes were observed in the Placebo group.CONCLUSION Adjunctive administration of P.acidilactici CCFM6432 not only augments the therapeutic efficacy of antide-pressants but also significantly ameliorates the symptoms of anhedonia in MDD.展开更多
Microcystin-LR(MC-LR)is a highly toxic category of biotoxins that can damage eye development and retinal structure in zebrafish,while probiotics can largely benefit the function of the retina.Although they both act on...Microcystin-LR(MC-LR)is a highly toxic category of biotoxins that can damage eye development and retinal structure in zebrafish,while probiotics can largely benefit the function of the retina.Although they both act on the visual system,whether probiotics can alleviate the visual damage caused by MC-LR in fish and the underlying mechanisms remains unclear.In this study,we exposed adult zebrafish for 28 days at MC-LR concentrations of 0,2.20,and 22.00μg/L with or without the probiotic Lactobacillus rhamnosus in the diet.MC-LR exposure alone resulted in structural damage to the retina and abnormal phototropic behavior,whereas L.rhamnosus could alleviate these damages.Biochemical analyses showed thatMCLR-induced abnormalities in apoptosis of ocular cells,retinal inflammatory responses,neurotransmission,and phototransduction were restored in the L.rhamnosus treatment group,indicating L.rhamnosus alleviated MC-LR-induced defects in the visual system and dysfunctions.This study underlines the defensive role of probiotics in protecting the host from environmental pollutants,which may provide guidance for the application of probiotics in aquaculture.展开更多
The gut microbiome,a complex ecosystem of microorganisms,has a significant role in modulating pain,particularly within orthopaedic conditions.Its impact on immune and neurological functions is underscored by the gut-b...The gut microbiome,a complex ecosystem of microorganisms,has a significant role in modulating pain,particularly within orthopaedic conditions.Its impact on immune and neurological functions is underscored by the gut-brain axis,which influences inflammation,pain perception,and systemic immune responses.This integrative review examines current research on how gut dysbiosis is associated with various pain pathways,notably nociceptive and neuroinflammatory mechanisms linked to central sensitization.We highlight advancements in meta-omics technologies,such as metagenomics and metaproteomics,which deepen our understanding of microbiome-host interactions and their implications in pain.Recent studies emphasize that gut-derived short-chain fatty acids and microbial metabolites play roles in modulating neuroinflammation and nociception,contributing to pain management.Probiotics,prebiotics,synbiotics,and faecal microbiome transplants are explored as potential therapeutic strategies to alleviate pain through gut microbiome modulation,offering an adjunct or alternative to opioids.However,variability in individual microbiomes poses challenges to standardizing these treatments,necessitating further rigorous clinical trials.A multidisciplinary approach combining microbiology,immunology,neurology,and orthopaedics is essential to develop innovative,personalized pain management strategies rooted in gut health,with potential to transform orthopaedic pain care.展开更多
BACKGROUND The gut microbiome is integral to human health,with emerging research underscoring its potential impact on ocular health through the gut-eye axis.Various ocular disorders,such as dry eye syndrome,retinal va...BACKGROUND The gut microbiome is integral to human health,with emerging research underscoring its potential impact on ocular health through the gut-eye axis.Various ocular disorders,such as dry eye syndrome,retinal vascular diseases,macular degeneration,and glaucoma,may be influenced by gut dysbiosis,which could significantly contribute to their development and progression.AIM To evaluate the influence of the gut microbiome on the pathogenesis and progression of various ocular diseases.METHODS An extensive search of the scientific literature was undertaken by adhering to Preferred Reporting Items for Systematic Reviews&Meta-Analyses standards,using PubMed(MEDLINE),Scopus,EMBASE,and the Cochrane Library as sources to locate studies addressing the relationship between the gut microbiome and human health.To capture all relevant publications,search terms were systematically applied across these major databases,without limiting the search by language or publication date.Inclusion criteria covered randomized controlled trials,non-randomized controlled trial,prospective studies,cross-sectional studies,and case-control studies.Out of the 3077 articles,36 full texts were included in the review.RESULTS Ocular health appears to be shaped by the gut microbial community through mechanisms such as immune regulation,preservation of the blood–retinal barrier,and the generation of protective metabolites.Disturbances in this microbial balance can provoke measurable alterations in host immunity,providing a plausible immunopathogenic pathway that connects intestinal dysbiosis with eye disease.Both laboratory models and early human data suggest that targeted interventions,including prebiotics,probiotics,synbiotics,and faecal microbiota transfer,hold therapeutic potential.CONCLUSION The gut–eye relationship reflects a multifaceted interaction in which the intestinal microbiome contributes to ocular health through complex biological pathways.Integrating microbiome assessments into diagnostic methods can revolutionize disease management through early detection and targeted interventions.Further,randomised controlled clinical trials are necessary for ocular diseases to prove causal relationships.展开更多
文摘Probiotical cell fragments (PCFs) are structural components of the probiotic cell lysate(s) and exhibit similar beneficial effects on the host as live probiotic bacteria. With cell fragment technology (CFT?), the structural fragments are isolated and purified from live probiotic cells. While observed to be strain-dependent as in the case of live probiotics, orally administered PCFs demonstrated a broad spectrum of immune modulation functions;anti-allergy;anti-inflammation;anti-bacterial and anti-viral properties;anti-mutagenic;and radioprotective and detoxification abilities in humans and animals. The PCFs mechanisms of action include events of motifs of cell wall peptidoglycans, DNA motifs, nucleotide containing components, lipoteichoic acids (LPAs), surface layer (S-layer) proteins, and cytoplasmic proteins. Different immunological in vivo-in vitro tests have shown that PCFs, essentially, have the ability to stimulate the macrophages, and induce cytokines such as interleukins, tumor necrosis factors (TNFs), interferons (IFNs), and natural killer (NK) cells. PCFs may be used as ingredients for foods and beverages or as nutritional supplements with long term stability and shelf-life up to 5 years. PCFs may also be used as health restorative ingredients in cosmetic products. The outcome of probiotics CFT? stands as an advantage to the food and pharmaceutical industries, regarding the formulation of novel products with unadulterated sensory characteristics of origin. Hence, PCFs are being characterized here as “novel nutraceutical ingredients” for health maintenance in both humans and animals.
文摘The evidence in this paper indicates that the alarming increase of common allergies can be reduced by the intake of particular “probiotics” or “paraprobiotics” along with food. This appears to build a consensus in the pharmaceutical and food communities about the role of probiotics in the prevention and treatments of common allergies. Food allergy is one of the common allergies, defined as an adverse health effect arising from a specific immune response that occurs reproducibly on exposure to a given food. Improving the digestion of foods and maintaining a healthy gastrointestinal (GI) tract is certainly critical to controlling food allergens. Therefore, the association between a leaky gut or an impaired intestinal permeability and food-allergenic reactions is explained. Gluten has been found to be somehow a justification for protein allergy, and should, therefore, be avoided by people with celiac disease. In several, in vitro models, surface layer (S- layer) proteins of selective paraprobiotics have shown potential in alleviating food allergies and intestinal disorders. Notably, lactobacilli paraprobiotics have proven to be the immediate immunomodulators against common allergies and other diseases, including viral (flu, hepatitis C), bacterial (bronchitis), asthma, chronic fatigue, fibromyalgia, gastrointestinal distress, and autism disorders in humans.
基金supported by grants from the Jiangxi Provincial Natural Science Foundation,No.20242BAB26134(to XF)the National Natural Science Foundation of China,Nos.82060638(to TC),82060222(to XF),82460237(to XF)+1 种基金the Major Disciplines of Academic and Technical Leaders Project of Jiangxi Province,Nos.20194BCJ22032(to TC),20213BCJL22049(to XF)Science and Technology Plan of Jiangxi Health Planning Committee,No.202210390(to XF).
文摘Parkinson’s disease is characterized by synucleinopathy-associated neurodegeneration.Previous studies have shown that glucagon-like peptide-1(GLP-1)has beneficial effects in a mouse model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.However,the effect of GLP-1 on intrinsic synuclein malfunction remains unclear.In this study,we investigated the effect of Lactococcus lactis MG1363-pMG36e-GLP-1 on parkinsonism in SncaA53T transgenic mice and explored the underlying mechanisms.Our data showed that Lactococcus lactis MG1363-pMG36e-GLP-1 inhibited dopaminergic neuronal death,reduced pathological aggregation ofα-synuclein,and decreased movement disorders in SncaA53T transgenic mice.Furthermore,Lactococcus lactis MG1363-pMG36e-GLP-1 downregulated lipopolysaccharide-related inflammation,reduced cerebral activation of microglia and astrocytes,and promoted cell survival via the GLP-1 receptor/PI3K/Akt pathway in the substantia nigra.Additionally,Lactococcus lactis MG1363-pMG36e-GLP-1 decreased serum levels of pro-inflammatory molecules including lipopolysaccharide,lipopolysaccharide binding protein,interleukin-1β,and interleukin-6.Gut histopathology and western blotting further revealed that Lactococcus lactis MG1363-pMG36e-GLP-1 increased the expression of gut integrity-related proteins and reduced lipopolysaccharide-related inflammation by reversing gut dysbiosis in SncaA53T transgenic mice.Our findings showed that the beneficial effect of Lactococcus lactis MG1363-pMG36e-GLP-1 on parkinsonism traits in SncaA53T transgenic mice is mediated by microglial polarization and the reversal of dysbiosis.Collectively,our findings suggest that Lactococcus lactis MG1363-pMG36e-GLP-1 is a promising therapeutic agent for the treatment of Parkinson’s disease.
文摘The term“gut microbiota”primarily refers to the ecological community of various microorganisms in the gut,which constitutes the largest microbial community in the human body.Although adequate bowel preparation can improve the results of colonoscopy,it may interfere with the gut microbiota.Bowel preparation for colonoscopy can lead to transient changes in the gut microbiota,potentially affecting an individual’s health,especially in vulnerable populations,such as patients with inflammatory bowel disease.However,measures such as oral pro-biotics may ameliorate these adverse effects.We focused on the bowel prepa-ration-induced changes in the gut microbiota and host health status,hypothesized the factors influencing these changes,and attempted to identify measures that may reduce dysbiosis,thereby providing more information for individualized bowel preparation for colonoscopy in the future.
基金supported by the National High Level Hospital Clinical Research Funding (2022-PUMCH-B-109)Chinese Academy of Medical Science Innovation Fund for Medical Sciences (CIFMS)(2021-I2M-1-020)。
文摘BACKGROUND: Sepsis, a common acute and critical disease, leads to 11 million deaths annually worldwide. Probiotics are living microorganisms that are beneficial to the host and may benefit sepsis outcomes, but their effects are stil inconclusive. This study aimed to evaluate the overal eff ect of probiotics on the prognosis of patients with sepsis.DATA RESOURCES: We searched several sources for published/presented studies, including Pub Med, EMBASE, Web of Science, the Cochrane Library and the US National Library of Medicine Clinical Trials Register(www.clinicaltrials.gov) updated through July 30, 2023, to identify all relevant randomized controlled trials(RCTs) or observational studies that assessed the effectiveness of probiotics or synbiotics in patients with sepsis and reported mortality. We focused primarily on mortality during the study period and analyzed secondary outcomes, including 28-day mortality, in-intensive care unit(ICU) mortality and other outcomes.RESULTS: Data from 405 patients in five RCTs and 108 patients in one cohort study were included in the analysis. The overall quality of the studies was satisfactory, but clinical heterogeneity existed. All adult studies reported a tendency for probiotics to reduce the mortality of patients with sepsis, and most studies reported a decreasing trend in the incidence of infectious complications, length of ICU stay and duration of antibiotic use. There was only one RCT involving children.CONCLUSION: Probiotics show promise for improving the prognosis of patients with sepsis, including reducing mortality and the incidence of infectious complications, particularly in adult patients. Despite the limited number of studies, especially in children, these findings will be encouraging for clinical practice in the treatment of sepsis and suggest that gut microbiota-targeted therapy may improve the prognosis of patients with sepsis.
文摘The gut microbiome comprises a vast community of microbes inhabiting the human alimentary canal,playing a crucial role in various physiological functions.These microbes generally live in harmony with the host;however,when dysbiosis occurs,it can contribute to the pathogenesis of diseases,including osteoporosis.Osteoporosis,a systemic skeletal disease characterized by reduced bone mass and increased fracture risk,has attracted significant research attention concerning the role of gut microbes in its development.Advances in molecular biology have highlighted the influence of gut microbiota on osteoporosis through mechanisms involving immunoregulation,modulation of the gut-brain axis,and regulation of the intestinal barrier and nutrient absorption.These microbes can enhance bone mass by inhibiting osteoclast differentiation,inducing apoptosis,reducing bone resorption,and promoting osteoblast proliferation and maturation.Despite these promising findings,the therapeutic effectiveness of targeting gut microbes in osteoporosis requires further investigation.Notably,gut microbiota has been increasingly studied for their potential in early diagnosis,intervention,and as an adjunct therapy for osteoporosis,suggesting a growing utility in improving bone health.Further research is essential to fully elucidate the therapeutic potential and clinical application of gut microbiome modulation in the management of osteoporosis.
基金supported by the National Natural Science Foundation of China(32371596)Key Natural Science Foundation of Zhejiang Province(Z25C030002)+2 种基金Science and Technology Innovation Yongjiang 2035 Key Research and Development Project of Ningbo(2024Z279)One Health Interdisciplinary Research Project(HZ202404)K.C.Wong Magna Fund in Ningbo University。
文摘Probiotic supplementation enhances the abundance of gutassociated Rhodobacteraceae species,critical symbionts contributing to the health and physiological fitness of Litopenaeus vannamei.Understanding the role of Rhodobacteraceae in shaping the shrimp gut microbiota is essential for optimizing probiotic application.This study investigated whether probiotics benefit shrimp health and fitness via the recruitment of Rhodobacteraceae commensals in the gut.Probiotic supplementation significantly enhanced feed conversion efficiency,digestive enzyme activity,and immune responses,thereby promoting shrimp growth.Additionally,probiotics induced pronounced shifts in gut microbial composition,enriched gut Rhodobacteraceae abundance,and reduced community variability,leading to a more stable gut microbiome.Network analysis revealed that the removal of Rhodobacteraceae nodes disrupted gut microbial connectivity more rapidly than the removal of nonRhodobacteraceae nodes,indicating a disproportionate role of Rhodobacteraceae in maintaining network stability.Probiotic supplementation facilitated the migration of Rhodobacteraceae taxa from the aquatic environment to the shrimp gut while reinforcing deterministic selection in gut microbiota assembly.Transcriptomic analysis revealed that up-regulation of amino acid metabolism and NF-κB signaling pathways was positively correlated with Rhodobacteraceae abundance.These findings demonstrate that probiotic supplementation enriches key Rhodobacteraceae taxa,stabilizes gut microbial networks,and enhances host digestive and immune functions,ultimately improving shrimp growth performance.This study provides novel perspectives on the ecological and molecular mechanisms underlying the beneficial effects of probiotics on shrimp fitness.
文摘This editorial,inspired by a recent study published in the World Journal of Gastrointestinal Oncology,covers the research findings on microbiota changes in various diseases.In recurrent colorectal polyps,the abundances of Klebsiella,Parvimonas,and Clostridium increase,while those of Bifidobacterium and Lactoba-cillus decrease.This dysbiosis may promote the formation and recurrence of polyps.Similar microbial changes have also been observed in colorectal cancer,inflammatory bowel disease,autism spectrum disorder,and metabolic syndrome,indicating the role of increased pathogens and decreased probiotics in these conditions.Regulating the gut microbiota,particularly by increasing probiotic levels,may help prevent polyp recurrence and promote gut health.This microbial intervention strategy holds promise as an adjunctive treatment for patients with colorectal polyps.
基金Supported by The Keimyung University Dongsan Medical Center in 2006.
文摘BACKGROUND Food protein-induced enterocolitis syndrome(FPIES)is the most serious type of non-immunoglobulin E(IgE)-mediated food allergic reaction manifesting as sepsis-like symptom,which can lead to shock.Saccharomyces boulardii(S.boulardii),a probiotic prescribed frequently in clinical settings,has been reported to trigger FPIES in an infant with soy-triggered FPIES.In this report,we describe a new clinical FPIES in which S.boulardii was the sole triggering factor of acute FPIES adverse reaction in seven healthy infants.CASE SUMMARY Seven FPIES cases triggered by only S.boulardii were gathered from 2011 to the present.None of the patients had previously experienced any allergic reaction to cow’s milk,soy,or complementary food.The age of the patients was 4-10-months old,and the symptoms of FPIES developed after ingestion of S.boulardii,which is mostly prescribed for the treatment of gastroenteritis or antibiotic-associated diarrhea.All patients experienced severe repetitive vomiting 1-3 hours after S.boulardii ingestion.Extreme lethargy,marked pallor,and cyanosis were also observed.No IgE-mediated hypersensitivity developed in any patient.Diarrhea was followed by initial intense vomiting in approximately 5-10 hours after S.boulardii ingestion,and only one case showed bloody,purulent,and foul-smelling diarrhea.The patients stabilized quickly,mostly within 6 hours.Symptoms got all improved within 24 hours after discontinuation of S.boulardii.CONCLUSION S.boulardii can be the sole trigger of acute FPIES and be prescribed cautiously even in healthy children without FPIES.
基金supported by the Key Project of Tibet Autonomous Region(XZ202001ZY0044NXZ202101ZD0002N-05).
文摘The prevalence of bacterial digestive diseases in plateau animals has caused considerable losses to the Tibetan live‑stock industry.Therefore,this study aimed to isolate safe lactic acid bacteria(LAB)with beneficial probiotic proper‑ties to protect yaks from intestinal diseases.After 16S rDNA matching,four strains of Lactobacillus fermentum(A4),Pediococcus pentosaceus(A3.4 and A1.2),and Pediococcus acidilactici(B1.9)were isolated from the intestinal tissues and content of healthy yaks.The results indicated that A4 was more tolerant to bile salt(0.3%),while A3.4 had better stability in an acidic(pH=3.0)environment.The results of the antibacterial activity test suggested that the isolates inhibited most pathogenic bacteria by up to 20%,except for A3.4,which inhibited Pasteurella and Staphylococcus aureus by more than 20%.Moreover,the results of the antioxidant test demonstrated that A4 and A3.4 had potent antioxidant activity.In addition,the drug sensitivity test revealed that the isolates were susceptible to commonly used antibiotics.In terms of safety,the isolates promoted growth,enhanced intestinal development,and protected the intestinal barrier without causing any adverse effects.In conclusion,LAB isolated from yak intestinal contents are potential probiotics with excellent antibacterial properties.
文摘BACKGROUND Diabetes is an epidemic condition affecting people globally with a high rate of morbidity and mortality.While various pharmacological and non-pharmacological treatment options are used,diabetes is still a non-treatable condition.Constant attempts are made to identify newer therapies that could support better management of the diabetes condition and improve overall quality of life.Numerous studies have supported the potential role of probiotics therapy in the diabetes condition.AIM To evaluate the efficacy of triple probiotic combination on glycaemic,metabolic,oxidative stress,and inflammatory parameters in the diabetic population.METHODS Randomized controlled trials evaluating the efficacy of the triple probiotic combination in diabetic patients were identified.The quality of the studies was evaluated using the PEDro scale while biasness between and within the studies was assessed using the Risk of Bias tool.Meta-analysis was conducted using RevMan software,and sensitivity analysis was performed using OpenMeta Analyst software.The study protocol was registered in PROSPERO(CRD42-024530999).RESULTS Five good-quality clinical trials were included.Low-to-moderate risk of bias was observed.Data from 300 participants were included(150 participants in both groups).Probiotics supplementation significantly improved glycaemic and insulin parameters(glucose level:-23.86 mg/dL;insulin level:-5.02μIU/mL;HOMA-IR:-1.82 score;QUICKI:+0.02 score;HOMA-B:-16.30 score;P<0.05 for all parameters),reduced oxidative stress and improved antioxidant parameters[TAC:+92.55 mmol/L;glutathione(GSH):+40.55μmol/L;nitric oxide(NO):+6.45μmol/L;malondialdehyde(MDA):-0.48μmol/L;hs-CRP:-2.24 mg/L;P<0.05 for all parameters except GSH],and improved lipid parameters(total cholesterol(TC):-3.43 mg/dL;triglycerides(TG):-4.26 mg/dL;low-density lipoprotein:-4.62 mg/dL;very low-density lipoprotein:-0.83 mg/dL;high-density lipoprotein(HDL):+1.83 mg/dL;TC/HDL ratio:-0.25;P<0.05 for HDL and TC/HDL ratio parameters)compared to the control group.CONCLUSION The combination of L.acidophilus,L.casei,and B.bifidum is effective in diabetic patients with cardio/renal complications.Further well-designed studies are warranted to support the results of current research.
文摘BACKGROUND Depression is a common mental-health disorder worldwide.Several studies have demonstrated the effects of gut microbiota-targeting interventions,such as probiotics,prebiotics,synbiotics,and postbiotics(PPSP),on depression.AIM To assess the potential benefits of PPSP on patients diagnosed with depressive disorder.METHODS A literature search of the PubMed,Web of Science,and Elsevier Science Direct databases for relevant studies published from database inception to March 2024 was performed.Studies that used a randomized controlled trial design and eva-luated differences in depression between PPSP and placebo were included.Depressive symptoms were assessed using a validated scale.Analysis was performed using Review Manager version 5.4(The Cochrane Collaboration,2020).RESULTS Fourteen studies comprising 906 patients with depressive symptoms were included.PPSP improved depression compared with placebo[SMD:-0.39(95%CI:-0.60 to-0.17);P<0.001].PPSP resulted in significant reductions in Hamilton Depression Rating Scale[MD:-1.72(95%CI:-2.57 to-0.88);P<0.001]and Beck Depression Inventory[MD:-2.69(95%CI:-4.67 to-0.71);P<0.001]scores.Sub-analysis confirmed the antidepressant effects of probiotics on depressive symp-toms[SMD:-0.32(95%CI:-0.48 to-0.16);P<0.001],with prebiotics exerting no apparent effect[SMD:-0.08(95%CI:-0.39 to-0.23);P=0.62],and synbiotics exerting statistically significant benefits[SMD:-1.09(95%CI:-1.45 to-0.73);P<0.001].CONCLUSION PPSP effectively alleviates depressive symptoms,and subgroup analysis supports the benefits of probiotics and synbiotics.Nevertheless,evidence supporting the use of PPSP for the treatment of depression remains insufficient.
文摘Schizophrenia is a complex neuropsychiatric disorder characterized by cognitive,emotional,and behavioral impairments.The microbiota-gut-brain axis is crucial in its pathophysiology,mediating communication between the gut and brain through neural,immune,endocrine,and metabolic pathways.Dysbiosis,or an imbalance in gut microbiota,is linked to neuroinflammation,systemic inflam-mation,and neurotransmitter disruptions,all of which contribute to the symp-toms of schizophrenia.Gut microbiota-derived metabolites,such as short-chain fatty acids,influence brain function,including immune responses and neurotrans-mitter synthesis.These findings suggest that microbial imbalances exacerbate schizophrenia,providing a novel perspective on the disorder’s underlying mechanisms.Emerging microbiota-targeted therapies—such as probiotics,prebiotics,dietary interventions,and fecal microbiota trans-plantation—show promise as adjunctive treatments,aiming to restore microbial balance and improve clinical outcomes.While further research is needed,targeting the micro-biota-gut-brain axis offers an innovative approach to schizophrenia management,with the potential to enhance patient outcomes and quality of life.
基金supported by National Science and Technology Fundamental Resources Investigation Program of China(2019FY100700).
文摘Hyperuricemia is a prevalent metabolic disorder resulting from dysregulation of purine metabolism,often accompanied by inflammation.It is characterized by an abnormal elevation in uric acid(UA)levels.In our investigation,the combined treatment with Lactiplantibacillus plantarum DY1 and quercetin suppressed the activity of xanthine oxidase and adenosine deaminase,decreased the levels of UA,tumor necrosis factor alpha(TNF-α)and interleukin 1β(IL-β),downregulated gene expression of urate transporter 1(URAT1)and glucose transporter 9(GLUT9),and upregulated organic anion transporter 1(OAT1)and ATP-binding cassette transporter subfamily G member 2(ABCG2).The combination increased the abundance of Lactobacillus and decreased the abundance of norank_f_norank_o__Clostridia_UCG-014 and Roseburia.Metabolomics analysis revealed that the combination of probiotics and quercetin exhibited distinct metabolic pathways compared to their individual administrations.When compared to probiotics alone,the combination led to alterations in glutathione metabolism(oxidized glutathione and glutathione)as well as sphingolipid metabolism(sphingosine and sphinganine).When compared to quercetin alone,the combination resulted in variations in tryptophan metabolism(indole-3-acetamide,5-hydroxy-L-tryptophan,indoleacetaldehyde,3-(3-indolyl)-2-oxopropanoic acid,3-indoleacetic acid and 3-methylindole)along with purine metabolism(UA,xanthosine,cyclic adenosine monophosphate(cAMP),adenosine diphosphate(ADP)and adenosine monophosphate(AMP)).The subsequent fecal microbiota transplantation proved that the effect of the combination on reducing UA levels was mediated by the gut microbiota.Therefore,this new combination can be considered a promising adjuvant therapy capable of synergistically alleviating hyperuricemia.
基金funded by the USDA National Institute of Food and Agriculture grants(2022-67016-37208 and 2024-67016-42415)the Ralph F.and Leila W.Boulware Endowment Fund,Oklahoma Agricultural Experiment Station Project H-3268+1 种基金Iowa Agriculture and Home Economics Experiment Station Project IOW05620supported by two separate USDA National Institute of Food and Agriculture Predoctoral Fellowship grants(2024-67011-42944 and 2021-67034-35184).
文摘Background Coccidiosis,caused by Eimeria parasites,is a major enteric disease in poultry,significantly impacting animal health,production performance,and welfare.This disease imposes a substantial economic burden,costing the global poultry industry up to$13 billion annually.However,effective mitigation strategies for coccidiosis remain elusive.While different chicken breeds exhibit varying resistance to coccidiosis,no commensal bacteria have been directly linked to this resistance.Methods To assess relative resistance of different breeds to coccidiosis,10-day-old Fayoumi M5.1,Leghorn Ghs6,and Cobb chickens were challenged with 50,000 sporulated Eimeria maxima oocysts or mock-infected.Body weight changes,small intestinal lesions,and fecal oocyst shedding were evaluated on d 17.Ileal and cecal digesta were collected from individual animals on d 17 and subjected to microbiome analysis using 16S rRNA gene sequencing.Results Fayoumi M5.1 chickens showed the lowest growth retardation,intestinal lesion score,fecal oocyst shedding,and pathobiont proliferation compared to Ghs6 and Cobb chickens.The intestinal microbiota of M5.1 chickens also differed markedly from the other two breeds under both healthy and coccidiosis conditions.Notably,group A Lactobacillus and Ligilactobacillus salivarius were the least prevalent in both the ileum and cecum of healthy M5.1 chickens,but became highly enriched and comparable to Ghs6 and Cobb chickens in response to coccidiosis.Conversely,Weissella,Staphylococcus gallinarum,and Enterococcus durans/hirae were more abundant in the ileum of healthy M5.1 chickens than in the other two breeds.Despite being reduced by Eimeria,these bacteria retained higher abundance in M5.1 chickens compared to the other breeds.Conclusions Fayoumi M5.1 chickens exhibit greater resistance to coccidiosis than Leghorn Ghs6 layers and Cobb broilers.Several commensal bacteria,including group A Lactobacillus,L.salivarius,Weissella,S.gallinarum,and E.durans/hirae,are differentially enriched in Fayoumi M5.1 chickens with strong correlation with coccidiosis resistance.These bacteria hold potential as probiotics for coccidiosis mitigation.
基金the National Key Research and Development Program(2022YFD1800400)Jiangsu Provincial Natural Science Foundation Project(BK20220746).
文摘As a natural alternative to antibiotics,probiotics have considerable potential for use in livestock farming.However,the current use of probiotics in livestock poses potential public health risks due to inadequate regulations,including issues such as the inferior quality and dissemination of antibiotic resistance.In this study,95 non-duplicate commercial probiotic products for livestock were collected from different regions of China.Our findings revealed that the labeling compliance rate for Lactobacillus was the lowest,at just 11%,and approximately 33.3%of the products were contaminated with opportunistic pathogens containing various virulence and antibiotic-resistance genes(ARGs).Isolates of Bacillus and Enterococcus from the products exhibited diverse clonal types and geographical dispersion,whereas certain Enterococcus exhibited close phylogenetic relationships to clones associated with human infectious diseases.Compared with Bacillus and Lactobacillus,Enterococcus exhibited a higher prevalence of ARGs.Specifically,the oxazolidine-resistance gene optrA,which is located on novel transferable plasmids,was found in one isolate of Enterococcus faecium(E.faecium).Using chicken models,we observed that the optrA-positive E.faecium disrupts the normal intestinal microbiota in chickens and alters the abundance of intestinal resistome and mobile genetic elements(MGEs).Furthermore,metagenomic analysis revealed that the optrA gene can be transferred via transposon IS1216E to commensal intestinal bacteria,including Enterococcus cecorum(E.cecorum),Enterococcus gallinarum(E.gallinarum),and Lactobacillus crispatus(L.crispatus)species.In summary,our study confirms that the probiotic products used in Chinese livestock production present problems such as non-compliance with good manufacturing practice(GMP)production standards and insufficient elucidation of the molecular genetic background of probiotic strains.The widespread use of low-quality Enterococcus strains containing various ARGs as probiotics could disrupt intestinal homeostasis and serve as a reservoir and source of ARGs.We emphasize the importance of carefully evaluating the use of Enterococcus strains as probiotics to avoid potential negative effects on livestock and human health.
基金Supported by the Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee,No.BJ2023086Wuxi Taihu Talent Project,No.WXTTP 2021.
文摘BACKGROUND Anhedonia,a hallmark symptom of major depressive disorder(MDD),is often resistant to common antidepressants.Preliminary evidence indicates that Pedio-coccus acidilactici(P.acidilactici)CCFM6432 may offer potential benefits in ame-liorating this symptomatology in patients with MDD.AIM To further assess the efficacy of P.acidilactici CCFM6432 in alleviating anhedonia in patients with MDD,using a combination of objective and subjective assessment tools.METHODS Adult patients with MDD exhibiting anhedonic symptoms were enrolled and randomly assigned to two treatment groups:One receiving standard antide-pressant therapy plus P.acidilactici CCFM6432,and the other receiving standard antidepressant treatment along with a placebo,for 30 days.Assessments were conducted at baseline and post-intervention using the Hamilton Depression Rating Scale(HAMD),Temporal Experience of Pleasure Scale(TEPS),and synchronous electroencephalography(EEG)during a"Doors Guessing Task."Changes in both clinical outcomes and EEG biomarkers,specifically the stimulus-preceding negativity(SPN)and feedback-related nega-tivity amplitudes,were analyzed.RESULTS Of the 92 screened participants,71 were enrolled and 55 completed the study(CCFM6432 group:n=27;Placebo group:n=28).No baseline differences were noted between the groups in terms of demographics,clinical assessments,or EEG metrics.A mixed-design analysis of variance revealed that the CCFM6432 group showed significantly greater improvements in both HAMD and TEPS scores compared to the Placebo group.Moreover,the CCFM6432 group demonstrated a significant increase in SPN amplitudes,which were inversely correlated with the improvements observed in HAMD scores.No such changes were observed in the Placebo group.CONCLUSION Adjunctive administration of P.acidilactici CCFM6432 not only augments the therapeutic efficacy of antide-pressants but also significantly ameliorates the symptoms of anhedonia in MDD.
基金supported by the National Key Research and Development Program of China(No.2023YFD2400900)the National Natural Science Foundation of China(Nos.32171619 and 32201388)+2 种基金the Youth project of the Natural Science Foundation of Hubei Province(No.2021CFB243)Hubei Province Excellent Young and Middle aged Science and Technology Innovation Team Project(No.T2022028)the Youth Talent Project of Science and Technology Research Program of Hubei Provincial Department of Education(No.Q20212503)。
文摘Microcystin-LR(MC-LR)is a highly toxic category of biotoxins that can damage eye development and retinal structure in zebrafish,while probiotics can largely benefit the function of the retina.Although they both act on the visual system,whether probiotics can alleviate the visual damage caused by MC-LR in fish and the underlying mechanisms remains unclear.In this study,we exposed adult zebrafish for 28 days at MC-LR concentrations of 0,2.20,and 22.00μg/L with or without the probiotic Lactobacillus rhamnosus in the diet.MC-LR exposure alone resulted in structural damage to the retina and abnormal phototropic behavior,whereas L.rhamnosus could alleviate these damages.Biochemical analyses showed thatMCLR-induced abnormalities in apoptosis of ocular cells,retinal inflammatory responses,neurotransmission,and phototransduction were restored in the L.rhamnosus treatment group,indicating L.rhamnosus alleviated MC-LR-induced defects in the visual system and dysfunctions.This study underlines the defensive role of probiotics in protecting the host from environmental pollutants,which may provide guidance for the application of probiotics in aquaculture.
文摘The gut microbiome,a complex ecosystem of microorganisms,has a significant role in modulating pain,particularly within orthopaedic conditions.Its impact on immune and neurological functions is underscored by the gut-brain axis,which influences inflammation,pain perception,and systemic immune responses.This integrative review examines current research on how gut dysbiosis is associated with various pain pathways,notably nociceptive and neuroinflammatory mechanisms linked to central sensitization.We highlight advancements in meta-omics technologies,such as metagenomics and metaproteomics,which deepen our understanding of microbiome-host interactions and their implications in pain.Recent studies emphasize that gut-derived short-chain fatty acids and microbial metabolites play roles in modulating neuroinflammation and nociception,contributing to pain management.Probiotics,prebiotics,synbiotics,and faecal microbiome transplants are explored as potential therapeutic strategies to alleviate pain through gut microbiome modulation,offering an adjunct or alternative to opioids.However,variability in individual microbiomes poses challenges to standardizing these treatments,necessitating further rigorous clinical trials.A multidisciplinary approach combining microbiology,immunology,neurology,and orthopaedics is essential to develop innovative,personalized pain management strategies rooted in gut health,with potential to transform orthopaedic pain care.
文摘BACKGROUND The gut microbiome is integral to human health,with emerging research underscoring its potential impact on ocular health through the gut-eye axis.Various ocular disorders,such as dry eye syndrome,retinal vascular diseases,macular degeneration,and glaucoma,may be influenced by gut dysbiosis,which could significantly contribute to their development and progression.AIM To evaluate the influence of the gut microbiome on the pathogenesis and progression of various ocular diseases.METHODS An extensive search of the scientific literature was undertaken by adhering to Preferred Reporting Items for Systematic Reviews&Meta-Analyses standards,using PubMed(MEDLINE),Scopus,EMBASE,and the Cochrane Library as sources to locate studies addressing the relationship between the gut microbiome and human health.To capture all relevant publications,search terms were systematically applied across these major databases,without limiting the search by language or publication date.Inclusion criteria covered randomized controlled trials,non-randomized controlled trial,prospective studies,cross-sectional studies,and case-control studies.Out of the 3077 articles,36 full texts were included in the review.RESULTS Ocular health appears to be shaped by the gut microbial community through mechanisms such as immune regulation,preservation of the blood–retinal barrier,and the generation of protective metabolites.Disturbances in this microbial balance can provoke measurable alterations in host immunity,providing a plausible immunopathogenic pathway that connects intestinal dysbiosis with eye disease.Both laboratory models and early human data suggest that targeted interventions,including prebiotics,probiotics,synbiotics,and faecal microbiota transfer,hold therapeutic potential.CONCLUSION The gut–eye relationship reflects a multifaceted interaction in which the intestinal microbiome contributes to ocular health through complex biological pathways.Integrating microbiome assessments into diagnostic methods can revolutionize disease management through early detection and targeted interventions.Further,randomised controlled clinical trials are necessary for ocular diseases to prove causal relationships.
